HIP Corporation (2136.T)
JPY 1087.0
(-0.91%)
JPY 1087.0
(-0.91%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 549.41 Million | 344.75 Million | 560 Million | 367.38 Million | 367.61 Million |
| Net Income | 494.41 Million | 589.35 Million | 589.43 Million | 532.96 Million | 379.7 Million |
| Depreciation & Amortization | 22.1 Million | 24.03 Million | 23.17 Million | 18.93 Million | 15.86 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 226.64 Million | -61.53 Million | 115.52 Million | 75 Thousand | -40.94 Million |
| Other non-cash items | 3.99 Million | -13.2 Million | -132.74 Million | -273.68 Million | 72.21 Million |
| Investing Cash Flow | 1.7 Million | -4.46 Million | -7.74 Million | -47.76 Million | -3.68 Million |
| Investments in PPE | -6.09 Million | -4.46 Million | -9.24 Million | -47.76 Million | -3.68 Million |
| Acquisitions | 3.72 Million | - | 1.5 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | 4.07 Million | - | - | - | - |
| Other Investing Activities | -1000.00 | - | - | -1000.00 | - |
| Financing Cash Flow | -214.64 Million | -170.08 Million | -120.27 Million | -96.63 Million | -95.62 Million |
| Debt repayment | -1.14 Million | -50 Million | -1.14 Million | -1.14 Million | -476 Thousand |
| Dividends payments | -159.34 Million | -118.93 Million | -119.12 Million | -95.49 Million | -95.14 Million |
| Common Stock Repurchased | -54.15 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1000.00 | -1000.00 | -1000.00 | -1000.00 | - |
| Accounts receivables | 29.17 Million | -13.25 Million | -29.07 Million | 43.3 Million | -26.72 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 2.19 Million | -2.02 Million | 90 Thousand | -917 Thousand | -758 Thousand |
| Other working capital | 195.28 Million | -46.25 Million | 144.51 Million | -42.31 Million | -13.45 Million |
| Cash at beginning of period | 3.41 Billion | 3.24 Billion | 2.81 Billion | 2.59 Billion | 2.32 Billion |
| Cash at end of period | 3.75 Billion | 3.41 Billion | 3.24 Billion | 2.81 Billion | 2.59 Billion |
| Capital Expenditure | -6.09 Million | -4.46 Million | -9.24 Million | -47.76 Million | -3.68 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 336.47 Million | 170.21 Million | 431.98 Million | 222.98 Million | 268.3 Million |
| Free Cash Flow | 543.32 Million | 340.29 Million | 550.75 Million | 319.62 Million | 363.93 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | 494.41 Million | 589.35 Million | 589.43 Million | 532.96 Million | 379.7 Million |
| Depreciation & Amortization | 22.1 Million | 24.03 Million | 23.17 Million | 18.93 Million | 15.86 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 226.64 Million | -61.53 Million | 115.52 Million | 75 Thousand | -40.94 Million |
| Other non-cash items | 3.99 Million | -13.2 Million | -132.74 Million | -273.68 Million | 72.21 Million |
| Investing Cash Flow | 1.7 Million | -4.46 Million | -7.74 Million | -47.76 Million | -3.68 Million |
| Investments in PPE | -6.09 Million | -4.46 Million | -9.24 Million | -47.76 Million | -3.68 Million |
| Acquisitions | 3.72 Million | - | 1.5 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | 4.07 Million | - | - | - | - |
| Other Investing Activities | -1000.00 | - | - | -1000.00 | - |
| Financing Cash Flow | -214.64 Million | -170.08 Million | -120.27 Million | -96.63 Million | -95.62 Million |
| Debt repayment | -1.14 Million | -50 Million | -1.14 Million | -1.14 Million | -476 Thousand |
| Dividends payments | -159.34 Million | -118.93 Million | -119.12 Million | -95.49 Million | -95.14 Million |
| Common Stock Repurchased | -54.15 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1000.00 | -1000.00 | -1000.00 | -1000.00 | - |
| Accounts receivables | 29.17 Million | -13.25 Million | -29.07 Million | 43.3 Million | -26.72 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 2.19 Million | -2.02 Million | 90 Thousand | -917 Thousand | -758 Thousand |
| Other working capital | 195.28 Million | -46.25 Million | 144.51 Million | -42.31 Million | -13.45 Million |
| Cash at beginning of period | 3.41 Billion | 3.24 Billion | 2.81 Billion | 2.59 Billion | 2.32 Billion |
| Cash at end of period | 3.75 Billion | 3.41 Billion | 3.24 Billion | 2.81 Billion | 2.59 Billion |
| Capital Expenditure | -6.09 Million | -4.46 Million | -9.24 Million | -47.76 Million | -3.68 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 336.47 Million | 170.21 Million | 431.98 Million | 222.98 Million | 268.3 Million |
| Free Cash Flow | 543.32 Million | 340.29 Million | 550.75 Million | 319.62 Million | 363.93 Million |
HPURF
3219
8464
HEMO
FFB
FMCCT